Product Introduction:
Glimisave M 1 Tablet SR is a combination of Glimepiride (1 mg), a sulfonylurea, and Metformin (500 mg SR), a biguanide. It is used to manage type 2 diabetes mellitus in adults when diet, exercise, and single therapy do not provide adequate glycemic control. This sustained-release (SR) formulation ensures steady glucose control throughout the day.
Uses:
-
Type 2 diabetes mellitus (non-insulin-dependent diabetes)
-
Blood sugar control in patients not adequately managed with monotherapy
Benefits:
-
Helps reduce both fasting and post-meal blood sugar levels
-
Improves insulin sensitivity and pancreatic insulin release
-
Sustained release action provides prolonged glucose control
-
Reduces the risk of diabetes-related complications
Composition:
-
Glimepiride 1 mg
-
Metformin Hydrochloride 500 mg (Sustained Release)
Side Effects:
Common side effects:
-
Nausea or stomach upset
-
Diarrhea
-
Headache
-
Dizziness
-
Low blood sugar (hypoglycemia)
Rare but serious side effects:
-
Lactic acidosis (very rare but serious with Metformin)
-
Allergic reactions
-
Liver function abnormalities
Safety Advice:
-
Take with meals to reduce stomach upset and risk of hypoglycemia
-
Monitor blood glucose regularly
-
Avoid skipping meals after taking the tablet
-
Not recommended in patients with severe kidney or liver impairment
-
Use with caution during pregnancy and breastfeeding
-
Avoid alcohol as it may increase the risk of lactic acidosis or hypoglycemia
-
Store in a cool, dry place away from light and moisture
